Physician profile
David Franklin Snipelisky
NPI 1699069088
$250,466.25
in general payments reported to CMS, 2019-2025
32 companies · $61K in 2025
The $61K reported for 2025 was more than what 95% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $14K · 2021: $6,871 · 2022: $55K · 2023: $65K · 2024: $32K · 2025: $61K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75K · Honoraria: $34K · Travel and Lodging: $25K · Consulting Fee: $12K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,368.81 |
| Honoraria | $33,800.00 |
| Travel and Lodging | $25,261.10 |
| Consulting Fee | $12,100.00 |
| Food and Beverage | $11,238.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $171,091.51 | 2019-2025 | |
| Impulse Dynamics (USA) INC. | $62,465.88 | 2022-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $6,653.06 | 2019-2025 | Cardiomems, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $2,123.52 | 2023 | Lifevest |
| Novartis Pharmaceuticals Corporation | $1,323.01 | 2019-2024 | Leqvio |
| Abiomed | $1,201.95 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $1,095.02 | 2024 | |
| Medtronic, INC. | $599.31 | 2023-2025 | Azure Xt Dr Mri Surescan, Hvad Pump Implant Kit, Micra |
| Boston Scientific Corporation | $493.21 | 2019-2025 | Watchman Flx, Watchman Access System, Sentinel |
| Biosense Webster, INC. | $459.00 | 2024-2025 | Carto 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $412.54 | 2020-2025 | Jardiance |
| Cvrx, INC. | $316.01 | 2021-2024 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $306.55 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $261.49 | 2019-2025 | Camzyos |
| Medtronic Vascular, INC. | $258.50 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $225.47 | 2019-2023 | Farxiga |
| Vifor Pharma, INC. | $214.58 | 2019 | |
| Amgen INC. | $202.00 | 2019-2025 | Repatha, Repatha |
| Alnylam Pharmaceuticals INC. | $143.14 | 2019-2023 | Onpattro |
| Cardiva Medical, INC. | $126.47 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Bridgebio Pharma, INC. | $95.95 | 2025 | Attruby |
| Cordis US Corp. | $86.96 | 2025 | Mynx Control Venous |
| Endotronix, INC. | $82.60 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Kiniksa Pharmaceuticals International, Plc | $39.47 | 2024 | Arcalyst |
| Procyrion, INC. | $34.60 | 2022 | |
| W. L. Gore & Associates, INC. | $32.52 | 2021 | |
| Heartflow, INC. | $29.84 | 2025 | |
| Amarin Pharma, INC. | $23.88 | 2019 | |
| Scpharmaceuticals INC. | $19.17 | 2023 | |
| Atricure, INC. | $17.60 | 2024 | |
| Chiesi USA, INC. | $16.12 | 2022 | |
| Novo Nordisk INC | $15.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Snipelisky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.